Newsroom

Filters: Biosimilar medicines
x
press-releases
x

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Press statement following meeting with Commission President Ursula von der Leyen on tariffs

9 April 2025

Read More

New Horizons for Biosimilar Medicines Policy: Delivering better access, outcomes, and biotech manufacturing in the future

3 April 2025

Read More

EU multiannual financial framework funding for critical medicines manufacturing vital for strategic autonomy

1 April 2025

Read More

IGBA Statement on trade barriers and their impact on healthcare systems and patients’ health

25 March 2025

Read More

Ambitious Critical Medicines Act vital to secure supply

11 March 2025

Read More

Medicines for Europe supports legal action against provisions in the Urban Wastewater Treatment Directive (UWWTD), which puts access to medicines at risk

10 March 2025

Read More

Pharma reform brings new opportunities for better regulation, access and security of medicines supply

27 February 2025

Read More

Harmonising Bioequivalence: Advancing Global Access to Generic Medicines

26 February 2025

Read More

STADA’s Stephan Eder sets Access, Manufacturing and Sustainability at heart of Medicines for Europe Presidency

13 January 2025

Read More

Industry Proposes Phased Rollout of ePI for Patient Safety and Environmental Sustainability

8 January 2025

Read More

Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]
Medicines For Europe